Jorge Haller is a Senior Director at Eli Lilly, specializing in gene therapy and analytical development. Currently, they lead the Process and Analytical Development team, overseeing quality control and regulatory support for AAV-based drug development. With extensive experience in managing partnerships and directing FDA-approved studies, Haller is dedicated to advancing treatments for rare diseases. Their prior roles include Director of Process and Analytical Development at Prevail Therapeutics and a Post-Doctoral Research Fellow at Harvard Medical School, contributing significantly to cholesterol metabolism and lipid transport research. Haller holds a PhD in Physiology & Biophysics from Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices